July 14, 2025

RB1 expression and HR proficiency define a poor-outcome molecular subtype of high grade serous ovarian carcinoma

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Analysis reveals HR proficiency and RB1 expression define a high-risk molecular subtype, suggesting new therapeutic approaches.

HRP-RBH tumors show significantly worse overall survival (35.9 months) compared to HRP-RBL, HRD-RBL, and HRD-RBH subgroups.
The study analyzed data from 272 TCGA HGSOC cases and 226 clinical cases to explore prognostic implications of HR and RB1.
Aneuploidy scores were notably higher in HRP-RBH tumors, indicating distinct genomic characteristics.
Molecular subtyping may assist in identifying high-risk patients and developing targeted treatments for HGSOC.

Strickland et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark